Weed, Brains, and Mental Health
- Griffin Oakley

- Sep 30, 2025
- 9 min read
Updated: Jul 25
Let’s start with this: I’m not here to take away your weed. I know some of you just clenched up like I was about to raid your stash. Relax. I’m not your mom, and I’m not the cops. My job is to keep it real about weed and mental health — what the science is actually finding, and how your favorite coping tools fit (or don’t) into that picture.
I’m not trying to talk you into a position, either. Good, bad, medicine, crutch. Those arguments are boring and nobody ever wins them. What I’m after is narrower. Is weed making your anxiety worse? Is it still helping you sleep, or does it just feel that way now? Is the thing you’re using still doing for you what you believe it’s doing?

Weed And Mental Health: Where Does It Actually Fit?
Okay, let’s talk cannabis. For some people, it’s a soft landing at the end of the day. For others, it’s a way to keep panic attacks at bay or help with sleep. But here’s the thing:
Weed isn’t neutral, and the calm and the anxiety don’t come from the same place. In controlled studies, THC tends to produce anxiety, especially at higher doses. The soothing gets attributed mostly to CBD, which doesn’t get you high and doesn’t flip anxious at higher doses the way THC does. Here’s the strange part: what people report about their own use runs the opposite direction from the lab results. Both findings are sitting in the same review.
Heavy, long-term use? The data gets messier. For people with bipolar, continuing to use through a manic or mixed episode is linked to worse recovery and more recurrence. The ones who quit looked about the same as people who never used at all. For everyone else it’s less dramatic. Focus and memory take a small hit, and most of it clears within a few days off. Though that research is on people in their late teens and twenties, who are the higher-risk group, not the average one.
If someone prescribes for you, psychiatrist, PCP, nurse practitioner, they should know how much you use. Not so they can talk you out of it. So they’re not adjusting a dose while a variable they can’t see is moving underneath them.
Age of first use matters more than almost anything else. Starting as a teenager raises the odds of a cannabis use disorder four to seven times over starting as an adult. If you started young, that isn’t a verdict on you. It’s information about why the pattern might feel harder to move than it does for someone who picked it up at 25.
And here’s the kicker: weed today is not the same weed your uncle smoked at a Grateful Dead show in 1975. Seized product went from about 4% THC to over 16% between 1995 and 2022, and dispensary flower and concentrates can top 40%. Concentrates hit fast and hit hard. Edibles do the opposite. They sneak up on you an hour or two later, when you’re just trying to fold laundry. What was a mellow buzz decades ago can now hit like a freight train.
The science isn’t saying “never touch it.” It’s saying: pay attention. Notice how you feel not just during the high, but the day after, the week after.
What Happens With Overuse

Stronger product, stronger dose. And the risks don’t scale politely. High-THC products make anxiety, paranoia, and panic more likely in the moment, especially at big doses or if you don’t use much. Over the long run they’re linked to more psychosis and more dependence. For depression and anxiety as diagnoses, that same review found the evidence mixed, which is worth saying out loud rather than rounding off.
Cannabinoid Hyperemesis Syndrome. A real condition where long-term heavy use locks you into cycles of intense nausea, vomiting, and stomach pain. The strangest part is the hot shower. Across published cases, 92% of people had found that compulsive hot bathing eased it — so consistently that it’s now part of how the condition gets spotted in the first place. Stopping is the only treatment anyone has established. In that same review, symptoms resolved after cessation in 97% of cases, and all 21 people who kept using kept having symptoms. Worth knowing what those numbers are and aren’t. These are published case reports, not a trial. But when the picture is that lopsided across that many people, it’s telling you something.
Cannabis Use Disorder (CUD). About 22% of people who use cannabis meet criteria for it. Wanting to cut down and not managing it. Using anyway while it quietly wears on work, relationships, or mood. The strongest predictor isn’t potency. It isn’t bad luck either. It’s how often. One review tracked this prospectively and found risk climbing at every step: roughly double at yearly use, four times at monthly, eight times at weekly, seventeen times at daily, all compared with not using at all. Not a cliff. A ramp. A steep one, and most people have no idea which part of it they’re standing on.
Mental health flare-ups. Daily use roughly triples the odds of a psychotic disorder. Daily use of high-potency product pushes it closer to five times. Researchers ran the numbers on Amsterdam and estimated that if high-potency cannabis vanished from the city, about half the first-episode psychosis cases would go with it. That last one assumes the association is causal, which is the researchers' own caveat and also the part still being argued over. Other researchers wrote into the same journal within months, pointing at genetic evidence suggesting the arrow may run the other way, with psychosis risk driving cannabis use rather than the reverse. The original authors pushed back. Hold the number loosely. Don't wave it away either.
Myth vs. Fact
Myth: “Weed is natural, so it can’t really hurt you.”
Fact: Poison ivy is natural too. Cannabis can absolutely cause a use disorder, nausea, vomiting, and worsen mental health when overused.
Myth: “That vomiting thing is just made up.”
Fact: Nope. Cannabinoid Hyperemesis Syndrome is in medical journals and ER charts. Doctors are recognizing it more now. Partly because more people use daily, partly because they finally know what they’re looking at.
Myth: “It’s safer than alcohol, so I’m fine.”
Fact: Safer doesn’t mean harmless — and honestly, on some measures it is safer. In one national study, 22.7% of drinkers became dependent at some point versus 8.9% of cannabis users. That’s a narrower measure than the 22% figure above. Dependence, not the full range of use disorder, and the data’s from the early 2000s, before today’s potency. Both numbers are real. They’re counting different things. And a real difference still isn’t the same as fine. They wreck different things, and both can do serious damage when pushed far enough.
Things Worth Trying
Find yourself on the frequency ladder. Not to feel bad about it. Because frequency has the clearest relationship to trouble of anything in this article, and it’s the variable most within reach. Daily to five days a week is a real change. Five to two is a real change. You don’t have to pick zero for the number to move.
If your head feels slow, give it three days before deciding that’s just who you are now. Most of that research is in younger users, so hold it loosely. But in the studies that required at least 72 hours between last use and testing, the differences in memory and attention stopped showing up. Which means what you’ve been calling my brain lately may just be the tail end of last night.
Expect the first week to lie to you. Among regular users in the general population, roughly one in six gets a real withdrawal syndrome on stopping: irritability, anxiety, appetite changes, and sleep that comes apart at the seams. Here’s the trap. It feels exactly like proof you needed it. It isn’t. It’s your system recalibrating. How long that takes varies more than anyone selling you a program will admit, and I’m not going to hand you a number I can’t back up. But it’s a phase, not your new floor.
Coming back after a break isn’t the same as never leaving. Tolerance runs backwards from what most people assume. The racing, too-much, why-did-I-do-this reaction to THC hits people who don’t use often harder than it hits daily users. In one study, frequent users given the same dose had noticeably smaller spikes in anxiety than people who rarely used. So take two weeks off, come back at your old amount, and you may get a rougher ride than you’re braced for. Start lower than feels necessary.
If you use it to sleep, be honest about what it’s doing. The best recent look at cannabis and sleep architecture, the measurable stages tracked in a lab, found it doesn’t reliably shift them much in either direction. That doesn’t mean it isn’t helping you fall asleep. It means the story about deep restorative sleep probably isn’t the mechanism. And the withdrawal point above cuts the other way. If the only thing keeping you from stopping is that you can’t sleep without it, that’s not evidence it’s working. That’s the loop.
Track the day after, not the night of. Everyone knows how they feel while high. Almost nobody tracks Tuesday morning after a Monday night. Two weeks of two-word notes will tell you more than any article will, including this one.
At The End Of The Day
Mental health is complicated. Weed is complicated. Life is complicated. Science is giving us new ways to understand how the pieces fit together, but the best data point will always be what you actually notice in your own life. If you notice your plant medicine making things heavier instead of lighter, that’s not you “failing,” that’s just information you can use.
If you're starting to wonder whether weed is still helping or quietly working against you, that's a conversation worth having. You don't have to figure it out alone.
Want new posts when they go up? Stay curious.
Griffin Oakley, MS, NCC, LMHC, LPC
Founder & Therapist, Curious Mind Counseling
📞 971-365-3642
About the Author
Griffin is a licensed telehealth therapist and the founder of Curious Mind Counseling, serving Oregon and Florida. His work focuses on complex trauma, attachment, and identity — and on the honest, judgment-free question of whether the things we use to cope are still working for us.
References
Bahji, A., Stephenson, C., Tyo, R., Hawken, E. R., & Seitz, D. P. (2020). Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: A systematic review and meta-analysis. JAMA Network Open, 3(4), e202370. https://doi.org/10.1001/jamanetworkopen.2020.2370
Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., La Barbera, D., Tarricone, I., Berardi, D., Szöke, A., Arango, C., Tortelli, A., Velthorst, E., Bernardo, M., Del-Ben, C. M., … Murray, R. M. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. The Lancet Psychiatry, 6(5), 427–436. https://doi.org/10.1016/S2215-0366(19)30048-3
Gillespie, N. A., Pasman, J. A., Treur, J. L., Derks, E. M., Verweij, K. J. H., & Vink, J. M. (2019). High-potency cannabis and incident psychosis: Correcting the causal assumption. The Lancet Psychiatry, 6(6), 464. https://doi.org/10.1016/S2215-0366(19)30174-9
Leung, J., Chan, G. C. K., Hides, L., & Hall, W. D. (2020). What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addictive Behaviors, 109, 106479. https://doi.org/10.1016/j.addbeh.2020.106479
Lopez-Quintero, C., Pérez de los Cobos, J., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2011). Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence, 115(1–2), 120–130. https://doi.org/10.1016/j.drugalcdep.2010.11.004
National Institute on Drug Abuse. (2024, September). Cannabis (marijuana). U.S. Department of Health and Human Services, National Institutes of Health. https://nida.nih.gov/research-topics/cannabis-marijuana
Petrilli, K., Ofori, S., Hines, L., Taylor, G., Adams, S., & Freeman, T. P. (2022). Association of cannabis potency with mental ill health and addiction: A systematic review. The Lancet Psychiatry, 9(9), 736–750. https://doi.org/10.1016/S2215-0366(22)00161-4
Robinson, T., Ali, M. U., Easterbrook, B., Coronado-Montoya, S., Daldegan-Bueno, D., Hall, W., Jutras-Aswad, D., & Fischer, B. (2022). Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. Drug and Alcohol Dependence, 238, 109582. https://doi.org/10.1016/j.drugalcdep.2022.109582
Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F. G., Moore, T. M., & Gur, R. C. (2018). Association of cannabis with cognitive functioning in adolescents and young adults: A systematic review and meta-analysis. JAMA Psychiatry, 75(6), 585–595. https://doi.org/10.1001/jamapsychiatry.2018.0335
Sharpe, L., Sinclair, J., Kramer, A., de Manincor, M., & Sarris, J. (2020). Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18, 374. https://doi.org/10.1186/s12967-020-02518-2
Sorensen, C. J., DeSanto, K., Borgelt, L., Phillips, K. T., & Monte, A. A. (2017). Cannabinoid hyperemesis syndrome: Diagnosis, pathophysiology, and treatment—a systematic review. Journal of Medical Toxicology, 13(1), 71–87. https://doi.org/10.1007/s13181-016-0595-z
Velzeboer, R., Malas, A., Wei, S., Berger, R., Parmar, V., & Lai, W. W. K. (2025). Cannabis and sleep architecture: A systematic review and meta-analysis. Sleep Medicine Reviews, 84, 102164. https://doi.org/10.1016/j.smrv.2025.102164
Winters, K. C., & Lee, C.-Y. S. (2008). Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug and Alcohol Dependence, 92(1–3), 239–247. https://doi.org/10.1016/j.drugalcdep.2007.08.005
Zorrilla, I., Aguado, J., Haro, J. M., Barbeito, S., López Zurbano, S., Ortiz, A., López, P., & Gonzalez-Pinto, A. (2015). Cannabis and bipolar disorder: Does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes? Acta Psychiatrica Scandinavica, 131(2), 100–110. https://doi.org/10.1111/acps.12366


